Lavipharm Overview

  • Founded
  • 1911

Founded
  • Status
  • Public

  • Employees
  • 171

Employees
  • Stock Symbol
  • LAVI

Stock Symbol
  • Share Price
  • $0.48

  • (As of Friday Closing)

Lavipharm General Information

Description

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ATH
Primary Office
  • Agias Marinas Street
  • PO Box 59
  • Paiania, 190 02
  • Greece
+30 21 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lavipharm Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.48 $0.46 $0.44 - $2.50 $7.83M 17M 10.7K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lavipharm Patents

Lavipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1613270-A4 Film forming polymers, methods of use, and devices and applications thereof Active 07-Apr-2003 0000000000
EP-1613270-B1 Film forming polymers, methods of use, and devices and applications thereof Active 07-Apr-2003 0000000000
EP-1613270-A2 Film forming polymers, methods of use, and devices and applications thereof Active 07-Apr-2003 0000000000
ES-2199094-T1 Film forming polymers, use procedures and applications of the same. Pending 19-Aug-1999 000000000
EP-1206282-A1 Film forming polymers, methods of use, and devices and applications thereof Inactive 19-Aug-1999 A61Q19/02
To view Lavipharm’s complete patent history, request access »

Lavipharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial